The mouse model of this TP53 mutant escapes the early onset of spontaneous tumorigenesis [10] but develops diabetes [11] as well as colon adenocarcinomas [12] upon the deficiency of nonhomologous end-joining (NHEJ). Here, TP53 is linked to diabetes mellitus.